Compare

HGH (Somatropin) vs Pentosan Polysulfate

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

HGH (Somatropin)

89 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 53% · Mixed 34% · Unfavorable overall 13%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Recovery
24
Digestive comfort
126
Skin appearance
71
Appetite control
86
Energy
178

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Anxiety
120
Flushing
25
Headache
36
GI discomfort
82
Dizziness
178

Self-reported dose per injection

Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg

Reports span 0.01–3 mg

0.01–0.025 mg
4
0.025–0.05 mg
11
0.05–0.1 mg
14
0.1–0.2 mg
19
0.2–0.4 mg
29
0.4–0.6 mg
24
0.6–1 mg
13
1–2 mg
4
2–3 mg
1

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing13stacking36side effects19hgh (somatropin)22

How repeat users are trending

Among repeat reporters, 63% said they felt similar to their last entry, 39% more positive, and 13% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 19 days · Based on 20 repeat reporters

Pentosan Polysulfate

2425 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 49% · Mixed 42% · Unfavorable overall 9%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Skin appearance
68
Appetite control
154
Energy
74
Mood
42
Focus
38

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Headache
164
GI discomfort
53
Dizziness
39
Fatigue
37
Nausea
37

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.2–0.4 mg

Reports span 0.025–3 mg

0.025–0.05 mg
4
0.05–0.1 mg
15
0.1–0.2 mg
19
0.2–0.4 mg
25
0.4–0.6 mg
22
0.6–1 mg
17
1–2 mg
6
2–3 mg
2

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing29stacking22side effects15pentosan polysulfate8

How repeat users are trending

Among repeat reporters, 59% said they felt similar to their last entry, 35% more positive, and 19% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 33 days · Based on 534 repeat reporters

Sources (7)

Published sources linked on the HGH (Somatropin) and Pentosan Polysulfate wiki pages.

  1. PubMed

    Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline

    Molitch ME, Clemmons DR, Malozowski S, et al. J Clin Endocrinol Metab. 2011

    Source
    Wiki study page →
  2. PubMed

    Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis

    Mameli C, Orso M, Calcaterra V, et al. Pharmacological research. 2023

    Source
    Wiki study page →
  3. FDA Drug Label

    ELMIRON (pentosan polysulfate sodium) — Prescribing Information

    Janssen Pharmaceuticals. FDA Drug Label. 1996

    Source
    Wiki study page →
  4. PubMed

    Pentosan polysulfate sodium for knee osteoarthritis: systematic review

    Bannuru RR, Osani MC, Vaysbrot EE, et al. Osteoarthritis Cartilage. 2020

    Source
    Wiki study page →
  5. PubMed

    The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment

    Ghosh P. Seminars in arthritis and rheumatism. 1999

    Source
    Wiki study page →